Recent Company News

• 05:00 PM ET Apr 14, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:06 AM ET Apr 14, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:08 PM ET Jun 25, 2025
  

  Adaptimmune Therapeutics downgraded to neutral from buy at Mizuho Securities ($0.25, 0.00)

• 07:35 AM ET May 13, 2025
  

  Adaptimmune Therapeutics reports Q1 EPS ($0.03) vs FactSet ($0.09) [8 est, ($0.19)-(0.02)] ($0.30, 0.00)

• 07:31 AM ET May 13, 2025
  

  Adaptimmune Reports Q1 Financial Results and Provides Business Update

• 04:14 PM ET Apr 11, 2025
  

  Adaptimmune Therapeutics downgraded to hold from buy at Jones ($0.22, 0.00)

• 04:43 PM ET Mar 24, 2025
  

  Adaptimmune Therapeutics discloses loan prepayment of $25.0M - 8-K ($0.28, 0.00)